
How Old is Too Old?
In virtually all studies of morbidity and mortality related to interventions or pathology in cardiovascular medicine and surgery, age is a compelling risk factor. As a somewhat chronic degenerative disease, atherosclerotic coronary artery disease develops over time—sometimes decades, before becoming clinically manifest. The older the patient, likely the greater burden of disease, and the lesser the ability to tolerate the manifestations, consequences and the treatments. Care of the elderly is resource-intense.
And yet, from the point of view of “return on investment,” even favorable results yield at best a limited number of “quality-adjusted life years”—the metric by which medical interventions are judged on a comparative cost basis. Despite the odious nature of the thought, extensive needs in the face of limited resources inevitably requires application of the “R” word—whether we like to admit it or not, rationing occurs by virtue of the choices we make or even by virtue of our failure to make them.
It is for reasons such as these, perhaps with the addition for concerns regarding the limited ability of the elderly to return to the work force that has led many foreign health care systems to restrict certain interventions on the basis of age. Indeed, perhaps even in our own country, where health care availability is not restricted by age, we see screening recommendations for various diseases such as breast cancer terminate at some arbitrary age even though the incidence of the underlying disease does not decline.
Perhaps the best we can hope for is that whatever decisions are made are considered based on the best scientific evidence available at the time. A remarkable study which the Florida Heart Research Institute recently reported to the American Heart Association, demonstrated that the very elderly, those age 80 and older, who underwent coronary artery bypass surgery, with current techniques and care, had a post-operative mortality comparable to their younger counterparts, and a life expectancy comparable to the general age-matched population.
Interestingly enough, when I presented this work, there was a companion paper from another center demonstrating similar findings for heart valve replacement surgery. In fact, some recent studies seem to indicate that careful analysis of risk factors no longer identifies age as an independent predictor of mortality for coronary bypass surgery.
Obviously, there is some pre-selection involved in these retrospective studies—the elderly patients who are accepted for surgery certainly represent a more potentially robust group than the total population of that age with that disease process. However, what is important to realize is that over the course of our study, a twelve year period extending from the late 1980’s to the early 2000’s , the post-operative mortality dropped progressively from around 15% to 2%.
This is a testimony to the advances in surgical and intensive care which is born from experience dealing with these patients. In other words, the underlying commitment to provide these elderly patients with the highest level of care resulted in dramatic improvements; had there not been that commitment, there would likely never have been that improvement. Therefore, before dismissing care of the elderly as too expensive, too resource intensive, or too unrewarding, we as a profession and as a society must pay careful attention to our priorities and our real capabilities.















